Open Access
Issue
Ann Toxicol Anal
Volume 25, Number 3, 2013
Page(s) 109 - 119
DOI https://doi.org/10.1051/ata/2013044
Published online 07 November 2013
  1. Sauer H, Hänsel R. Kawalaktone und Flavonoide aus einer endemischen Piper-Art Neu Guineas. Arch Pharmazie. 1967; 300: 443–458.
  2. Alexander K. Kava in the north: a study of kava in Arnhem Land Aboriginal communities. Darwin: North Australia Research Unit, The Australian National University, 1985.
  3. Alexander K, Watson C, Fleming J. Kava in north: a research report on current patterns of kava use in Arnhem Land Aboriginal communities. Darwin: North Australia Research Unit, The Australian National University, 1987.
  4. Cawte J. Psychoactive substances of the South Seas: betel, kava and pituri. Aust N Z J Psychiatry. 1985; 19: 83–87. [CrossRef] [PubMed]
  5. Gajdusek DC. Recent observations on the use of kava in the New Hebrides. In: Efron DM, Holmstedt B, Kline NS, eds. Ethnopharmacologic search for psychoactive drugs. New York: Raven Press 1979: 119–125.
  6. Barguil Y, Mermond S, Kintz P, Villain M, Choblet E, Cirimele V, Cabalion P, Duhet D, Charlot JY. L’abus de Daturas et de kava en Nouvelle-Calédonie : une pratique inquiétante. Ann Toxicol Anal. 2006; 18: 33–43. [CrossRef]
  7. Cabalion P, Barguil Y, Duhet D, Mandeau A, Warter S, Russmann S, Tarbah F, Daldrup T. Kava in modern therapeutic uses: to a better evaluation of the benefit/risk relation. Researches in New Caledonia and in Futuna. 5th European Symposium of Ethnopharmacology, Valencia, Spain, 8th-10th May 2003.
  8. Barguil Y, Cabalion P, Guillaudeux T, Isnard C, Choblet E, Hnawia E, Nour M. Valorisation d’une plante traditionnelle océanienne. Exemple du kava (Piper methysticum Forst f.) : questions, éléments de réponses et perspectives. Ethnopharmacologia. 2010; 45: 27–34.
  9. Rasmussen AK, Scheline RR, Solheim E, Hänsel R. Metabolism of some Kava Pyrones in Rat. Xenobiotica. 1979; 9: 1–16. [CrossRef] [PubMed]
  10. Köppel C, Tenczer J. Characterisation of urinary metabolites of D,L-kavain. J Chromatogr. 1991; 591: 207–211.
  11. Duffield AM, Jamieson DD, Lidgard RO. Identification of some human urinary metabolites of the intoxicating beverage kava. J Chromatogr. 1989; 475: 237–281. [CrossRef]
  12. Tarbah FA, Mahler H, Temme O, Daldrup T. Mass spectral characterisation of hepatic cell metabolites of D,L-kavain using HPLC and GC/MS systems. Special issue: 37th TIAFT triennial meeting “Problems of Forensic Sciences”. 1999; 52: 173–180.
  13. Johnson D, Trenendorf A, Stecker K, Stern U. Neurophysiologisches Wirkprofil und Verträglichkeit von Kava-Extrakt WS 1490. TW Neurol Psychiatr. 1991; 5: 349–354.
  14. Tarbah F, Barguil Y, Weinmann W, Mueller C, Duhet D, Cabalion P, Kardel B, Daldrup T. Death after consumption of kava beverage in combination with alcohol and cannabis. Beiträge zum XIII Symposium der Gesellschaft für Toxikologische und Forensische Chemie. Mosbach; 2004: 101–108.
  15. Tarbah F, Mahler H, Kardel B, Weinmann W, Hafner D, Daldrup T. Kinetics of kavain and its metabolites after oral application. J Chromatogr B. 2003; 789: 115–130. [CrossRef]
  16. Tarbah F. Analytical studies on the metabolism of kavain in human specimens and liver cell lines. Thesis. Düsseldorf: Heinrich Heine Universität; 2003.
  17. Hänsel R. Characterisation and physiological activity of some kava constituents. Pacific Sci. 1968; 22: 293–313.
  18. Hänsel R, Langhammer L, Rimpler H. Analytische Studien an Kawa-Laktonen: UV-absorptiometrische Untersuchungen. Arch Pharmazie. 1967; 300: 157–168. [CrossRef]
  19. Duve RN, Prasad J. Gas-liquid chromatographic determination of major constituents of Piper methysticum. Analyst. 1981; 106: 160–165. [CrossRef]
  20. He X, Lin L, Lian J. Electrospray high performence liquid chromatography-mass spectrometry in phytochemical analysis of kava (Piper methysticum) extract. Planta Med. 1997; 63: 70–74. [CrossRef] [PubMed]
  21. Duffield AM, Lidgard RO. Analysis of kava resin by gas chromatography and electron impact and methane negative ion chemical ionisation mass spectrometry: new trace constituents of kava resin. Biomed Environ Mass Spectrom. 1986a; 13: 621–626. [CrossRef]
  22. Hänsel R, Woelk H, Volz P, Faust. Therapie mit Kava-Kava. Stuttgart: Aesopus-Verlag 1999: 1–80.
  23. Hölzl J, Juretzek W, Schneider G, Stahl-Biskup E. Kava-kava rhizoma (Kavakavawurzelstock). In: Hagers Handbuch der Pharmazeutischen Praxis. Berlin, Heidelberg, New York: Springer 1994: 191–220.
  24. Hänsel R, Kammerer S. Kava-Kava. Basel: Aesopus-Verlag 1996: 18.
  25. Singh YN. Kava: An overview. J Ethanopharmacol. 1992; 37: 13–45. [CrossRef]
  26. Kintz P. Cheveux et toxicologie médico-judiciaire. In : Kintz P (coordinateur). Traité de toxicologie médico-judiciaire. Paris : Elsevier Masson SAS 2012: 257–275.
  27. Villain M, Cirimele V, Tracqui A, Ricaut FX, Ludes B, Kintz P. Testing for kavain in human hair using gas chromatography-tandem mass spectrometry. J Chromatogr B. 2003; 25: 351–354. [CrossRef]
  28. Pragst F, Rothe M, Spiegel K, Sporkert F. Illegal and therapeutic drug concentrations in hair segments – a timetable of drug exposure? Forensic Sci. 1997; 84: 225–236. [CrossRef] [PubMed]
  29. Pötsch L, Skopp G, Moeller MR. Zum Suchtmittelnachweis in Haaren: Eine biochemische Erklärung für den endogenen Einbau von Pharmaka und illegalen Drogen ins Haar während der Anagenphase. Rechtsmedizin. 1996; 7: 1–5. [CrossRef]
  30. Drummer OH, Cooper FJ. Detection of anti-depressant drugs in hair. In: Hair analysis in forensic toxicology workshop. Abu Dhabi, 1995.
  31. Tarbah FA, Daldrup T. Fluid/fluid extraction method for general unknown drug screening using an organic mixture of dichloromethane/diethylether. Medicina Legalis Baltica. 1997; 8: 123–127.
  32. Barguil Y, Anger J-P. Kava in Intoxications par les plantes. In : Kintz P (coordinateur). Traité de toxicologie médico-judiciaire. Paris : Elsevier Masson SAS 2012: 679–681.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.